Valuation: Boston Scientific Corporation

Market Cap 73.13B 63.31B 59.17B 54.08B 102B 6,974B 104B 694B 272B 3,489B 275B 269B 11,621B P/E 2026 *
18.9x
P/E 2027 * 19.6x
Enterprise Value 81.85B 70.85B 66.23B 60.53B 114B 7,806B 116B 777B 305B 3,905B 307B 301B 13,006B EV / Sales 2026 *
3.83x
EV / Sales 2027 * 3.52x
Free-Float
82.49%
Yield 2026 *
-
Yield 2027 * -
1 day+1.07%
1 week+4.19%
Current month+7.98%
1 month+12.71%
3 months-6.43%
6 months-32.04%
Current year-47.08%
1 week 47.1
Extreme 47.1
50.82
1 month 42.2
Extreme 42.2
50.82
Current year 42.2
Extreme 42.2
100.9
1 year 42.2
Extreme 42.2
109.5
3 years 42.2
Extreme 42.2
109.5
5 years 34.98
Extreme 34.98
109.5
10 years 19.67
Extreme 19.67
109.5
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Date Insider Type Main position Quantity % Market Cap.
05/08/26 Buy

Director

2,100 0.0001%
04/08/26 Buy

Director

140 0.0000%
03/08/26 Buy

Chief Executive Officer

208,359 0.0141%
Change 5-day change 1-year change 3-year change Capi.($)
+2.33%+4.19%-51.08%-0.79% 73.13B
+0.96%+4.47%+30.16%+9.58% 222B
+2.25%+6.01%+4.39%-18.65% 147B
+3.85%+4.79%-16.32%+29.12% 139B
+2.57%+3.61%+17.46%+17.57% 53.05B
+0.52%+1.03%-14.14%-16.51% 50.36B
+1.88%+6.38%+29.75%+16.51% 42B
+1.21%+9.88%+46.43%+42.33% 40.43B
+1.63%+4.60%+1.31%+0.89% 32.95B
+3.83%+2.26%-22.49%+24.23% 31.74B
Average +1.28%+217.82%+2.55%+10.43% 83.15B
Weighted average by Cap. +0.82%+304.83%+4.81%+8.02%

Financials

2026 *2027 *
Net sales 21.37B 18.5B 17.29B 15.8B 29.78B 2,038B 30.24B 203B 79.55B 1,019B 80.23B 78.48B 3,395B 22.34B 19.34B 18.07B 16.52B 31.13B 2,130B 31.62B 212B 83.17B 1,066B 83.87B 82.04B 3,550B
Net income 3.84B 3.33B 3.11B 2.84B 5.36B 367B 5.44B 36.47B 14.31B 183B 14.43B 14.12B 611B 3.74B 3.24B 3.03B 2.77B 5.21B 357B 5.29B 35.48B 13.92B 178B 14.04B 13.73B 594B
Net Debt 8.72B 7.55B 7.05B 6.45B 12.15B 831B 12.34B 82.71B 32.46B 416B 32.73B 32.02B 1,385B 5.45B 4.72B 4.41B 4.03B 7.6B 520B 7.72B 51.73B 20.3B 260B 20.47B 20.02B 866B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
59,000
Date Price Change Volume
10/08/26 $50.46 +2.33% 18,994,452
07/08/26 $49.31 +0.02% 11,447,002
06/08/26 $49.30 +3.27% 21,398,972
05/08/26 $47.74 -2.75% 16,512,147
04/08/26 $49.09 +1.36% 21,565,121
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
50.46USD
Average target price
62.69USD
Spread / Average Target
+24.24%

Quarterly revenue - Rate of surprise